Efficacy and safety of adalimumab (HUMIRA®) in European clinical practice:: The react trial

被引：0
|
作者：
Burmester, GR
Sáez, IM
Malaise, M
da Silva, JC
Webber, DG
Kupper, H
机构：
[1] Humboldt Univ, Univ Klinikum Charite, Berlin, Germany
[2] HGU Gregorio Maranon, Madrid, Spain
[3] CHU, Liege, Belgium
[4] Hosp Garcia Orta, Serv Reumatol, Almada, Portugal
[5] Abbott GmbH & Co KG, Immunosci, Ludwigshafen, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of adalimumab (Humira®) in European clinical practice:: The ReAct trial
    Burmester, GR
    Wordsworth, P
    Mariette, X
    Sáez, IM
    Bijlsma, JWJ
    Webber, DG
    Kupper, H
    RHEUMATOLOGY, 2005, 44 : I23 - I24
  • [2] Efficacy and safety of adalimumab (HUMIRA®) in Canadian clinical practice.: A comparison of the Canadian and the European practice:: The canact and the react trial to
    Cividino, A
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 425 - 425
  • [3] Efficacy and safety of adalimumab (HUMIRA®) in Canadian clinical practice.: A comparison of the Canadian and the European practice:: The CanACT and the ReACT trial
    Cividino, A
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) : 1401 - 1401
  • [4] Efficacy and safety of adalimumab (Humira®) in Canadian clinical practice:: Results from the canact trial
    Cividino, Alfred
    Haraoui, Paul
    Keystone, Edward
    Stewart, Jackie
    Guerette, Benoit
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1609 - 1609
  • [5] Efficacy and safety of adalimumab (Humira®) in Canadian clinical practice:: Results from the canact trial
    Haraoui, P.
    Cividino, A. A.
    Keystone, E. C.
    Stewart, J. C.
    Guerette, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 320 - 320
  • [6] Efficacy evaluation of adalimumab (HUMIRA®) by dose and administration route of concomitant methotrexate in widespread clinical practice (react trial)
    Bombardieri, S
    Tzioufas, AG
    McKenna, F
    Beat, MA
    Spencer-Green, GT
    Kupper, H
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 428 - 428
  • [7] Safety and efficacy of adalimumab (Humira®) in patients with rheumatoid arthritis in Germany:: React study
    Burmester, GR
    Alten, R
    Tony, H
    Liman, W
    Gromnica-Ihle, E
    Stierle, HE
    Zeidler, H
    Von Hinüber, U
    Kellner, H
    Häntzschel, H
    Lemma, E
    Zeise, E
    Kupper, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 266 - 266
  • [8] Efficacy evaluation of adalimumab (HUMIRA®) in patients with single and multiple prior biologics in the ReAct trial.
    Bombardieri, S
    Tzioufas, AG
    McKenna, F
    Michel, BA
    Webber, DG
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S187 - S188
  • [9] Rapid response to adalimumab (HUMIRA®) after first dose:: The react trial
    Bombardieri, S
    Moutsopoulos, HM
    McKenna, F
    Michel, B
    Webber, DG
    Kupper, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 261 - 261
  • [10] The ReAct trial:: Efficacy evaluation of adalimumab (Humira®) in patients switching from prior biologic DMARD therapies
    McKenna, F
    Bombardieri, S
    Tzioufas, AG
    Malaise, MG
    Webber, DG
    Kupper, H
    RHEUMATOLOGY, 2005, 44 : I2 - I3
12345